Cargando…
Zoledronate inhibits fibroblasts’ proliferation and activation via targeting TGF-β signaling pathway
BACKGROUND: Previous preclinical and clinical studies have demonstrated that zoledronate might inhibit neointimal hyperplasia at least partly by inhibiting the proliferation, adhesion and migration of vascular smooth muscle cells (VSMCs). However, whether zoledronate influences fibroblasts’ prolifer...
Autores principales: | Zhao, Zichang, Shen, Wei, Zhu, Hanbin, Lin, Lin, Jiang, Gening, Zhu, Yongzhe, Song, Hongyuan, Wu, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147205/ https://www.ncbi.nlm.nih.gov/pubmed/30271117 http://dx.doi.org/10.2147/DDDT.S168897 |
Ejemplares similares
-
Jia-Shen decoction-medicated serum inhibits angiotensin-II induced cardiac fibroblast proliferation via the TGF-β1/Smad signaling pathway
por: Cui, Lin, et al.
Publicado: (2016) -
miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway
por: Zeng, Xiangming, et al.
Publicado: (2017) -
Inhibition of Wilms' Tumor Proliferation and Invasion by Blocking TGF-β Receptor I in the TGF-β/Smad Signaling Pathway
por: Shi, Qinlin, et al.
Publicado: (2020) -
Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
por: Wang, Xueling, et al.
Publicado: (2023) -
Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway
por: Lin, Hung-Yun, et al.
Publicado: (2018)